ROSEN, A LONGSTANDING AND TRUSTED FIRM, Encourages Treace Medical Concepts, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – TMCI

Group 1 - A class action lawsuit has been filed against Treace Medical Concepts, Inc. for securities purchased between May 8, 2023, and May 7, 2024 [1] - Investors who purchased Treace Medical securities during the class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2] - The lawsuit alleges that Treace Medical made false or misleading statements regarding competition affecting the demand for its primary product, the Lapiplasty 3D Bunion Correction System, leading to a decline in revenue [5] Group 2 - The Rosen Law Firm, which is representing the investors, has a strong track record in securities class actions, having secured over $438 million for investors in 2019 alone [4] - The firm has been recognized for its success in securities class action settlements, being ranked No. 1 by ISS Securities Class Action Services in 2017 [4] - Investors can join the class action by submitting a form or contacting the firm directly for more information [3][6]